Shareholder Lewis Merenstein has claimed in court that the conversion of Medtronic stock to the combined company with Covidien will lead to a substantial loss for Medtronic shareholders.
Medtronic is now stuck with a nearly $221 million tax dispute with the Internal Revenue Service as a result of buying Covidien last year.
If you’re helping clients navigate big changes—from the surge in GLP-1 demand to AI to the growing pressure to demonstrate ROI – we want your thoughts.
It’s only been a few months since Covidien acquired wearable device maker Zephyr, but it’s already licensed the company’s biopatch to healthcare IT provider Geneia. It is the first deal of its kind for Geneia and is designed to support its new channel for home monitoring of patients, according to a company statement. Geneia will […]
Update below A discussion about wearable technology highlighted the need for hospitals to develop more effective ways of patient monitoring to avoid the grim reality of finding patients dead in bed from respiratory distress, for example. Covidien Vice President and General Manager of Patient Monitoring, Matthew Anderson, emphasized the needs in low acuity care for […]
Aside from the tax benefits, I was interested in finding out what some of the other driving forces were behind Medtronic’s $42.9 billion deal to acquire Covidien. A phone chat with Charles Whelan, Director of Consulting for Healthcare and Life Sciences for North America at Frost & Sullivan, highlighted some of the underlying trends in […]
Corporate inversion is front page news as Medtronic (NYSE: MDT) acquires Covidien (NYSE: COV) for $42.9 billion and establishes corporate offices in Ireland. It follows a similar path of tech giants Google and Microsoft, which have set up subsidiaries in Ireland. Although it plans to keep its production facilities in Minnesota, Medtronic wants to benefit […]
Balancing healthcare benefits and insurance costs requires research. From becoming a Difference Card member to offering wellness resources, there are many ways to improve healthcare at low cost.
Covidien, the medical device manufacturer, has acquired Zephyr Technology Corp. for an undisclosed amount. Rhonda Luniak, a vice president of communications at Covidien, confirmed the deal, originally reported by MobiHealthNews. Luniak told MedCity News in a phone interview that Covidien (NYSE: COV) acquired the business in March. The company’s first wearables acquisition will fit into […]
Covidien (COV) announced it will sell its Confluent Surgical line to Integra LifeSciences (IART) probably effective by March 31, 2014, pending regulatory approval. The product line brought in $65 million for the medical devices company in 2012. Integra will pay $235 million for the line, which includes DuraSeal, the first FDA-approved product that provides watertight […]
Medtech Women will focus on value in healthcare at its annual Vision conference on Sept. 10 in Menlo Park, Calif. According to the organization’s website, the group brings together medtech’s “business leaders, financial investors, researchers, physicians and experts in new product commercialization.” “A key pillar of the MedtechVision conference is fostering a forum that provokes […]
Medical device maker Covidien, which has operations in New Haven and North Haven, won a patent infringement case in U.S. District Judge Janet Bond Arterton's court in New Haven Thursday. Covidien sued Ethicon Endo-Surgery in 2004, after it introduced a...
Innovative sterilization cases and trays are instrumental in reducing infection risk in medical settings. Learn notable things about them and their makers.
Medical device maker Covidien (NYSE:COV) announced Wednesday that an abdominal stapler product was being recalled and discontinued after it received a single report of injury. Covidien said that the Duet TRS Universal Straight and Articulating Single-Use Loading Units, a stapler, had injured a patient after abdominal surgery. The product is typically used in “bariatric surgery […]
After hearing of injury reports from patients that included burns, Covidien, (NYSE:COV) is recalling certain electrode kits and grounding pads. The Mansfield, Massachusetts medical device maker said that it is withdrawing the DGPHP RFA High-Power Single Use Grounding Pads and Cool-tip RFA Electrode Kits that Contain DGPHP RFA High-Power Single Use Grounding Pads. The affected lots […]
The U.S. Food and Drug Administration has classified Covidien’s Aug. 4 voluntary recall of certain Shiley adult tracheostomy tubes as a Class I. Class I recalls are the most serious because the products in question have the potential to cause severe injury or death. Covidien recalled some of these tubes because of leakage and/or “disconnection […]
In talking about the medical device industry’s role in the rapidly shifting healthcare industry, the president of Covidien’s Global Vascular Therapies business sounded a lot like Medtronic CEO Omar Ishrak. “We have gotten away by not demonstrating the economic value of products,” said Stacy Enxing Seng, at a Women’s Leadership event Thursday organized in the […]
Mergers and acquisitions are an essential tenet of capitalism. They are the route many companies take to grow their businesses. But there are many failures amidst successful M&As. Remember the much-ballyhooed Time Warner-AOL Warner merger that turned out to be a real disaster. So here are a few golden rules of mergers and acquisitions. […]